| Literature DB >> 34436645 |
Andrea Cacciamani1, Fabio Scarinci2, Luca Bruno2, Bijorn Omar Balzamino2, Concetta Cafiero3, Agnese Re4, Pamela Cosimi2, Guido Ripandelli2, Alessandra Micera2.
Abstract
PURPOSE: The purpose of this study is to investigate whether phacoemulsification can generate aerosolized single-stranded RNA (ssRNA) and retain sequence integrity using an artificial eye model for experimental cataract surgery.Entities:
Keywords: 3D visual screen; Aerosol; COVID-19; Eye model; Nucleic acids; Personal protective equipment; Phacoemulsification cataract
Mesh:
Substances:
Year: 2021 PMID: 34436645 PMCID: PMC8387550 DOI: 10.1007/s00417-021-05350-6
Source DB: PubMed Journal: Graefes Arch Clin Exp Ophthalmol ISSN: 0721-832X Impact factor: 3.117
Fig. 1Description of artificial eye model. The simulation of phacoemulsification for cataract surgery was performed in a wet lab using an eye to investigate the possibility of aerosol transmission (A). Overview of the surgical training station used for simulation activity (b). Note that the model is placed on a support specific for the training simulation (C). The eye model is framed (C, green square)
Fig. 2Probe extraction and cDNA synthesis. Serial single-stranded RNA solutions (dilution factor 2) were introduced into the anterior chamber of the mock-up (400 µL/eye model) and prepared for phacoemulsification experiments. The simulation of phacoemulsification surgery was performed in a wet lab. Spectral absorbance acquisition of standard dilutions (A) and aerosol extracted (B) RNAs; Representative 2% agarose gel (C, E, G) and the related densitometric analysis (D, F, H) of resolved complementary DNA products, previously synthesized from the following: the total RNA standard solutions (C, D), anterior chamber (E, F), and strip/aerosol (G, H) RNAs. From left to right: M, DNA ladder and 1st–6st (st, standard; c); 1c–6c (c, chamber; D) and 1 s–6 s (s, strip; E). Note the absence of signals at lower concentrations. Densitometric analysis was performed using ImageJ software
Fig. 3Representative 3D-assisted surgery session. Picture depicting a phacoemulsification session in the surgery room. Note that the surgeon was wearing a face shield over 3D glasses (see red arrows in upper left insert), while performing the surgery with a 3D-visualization system (NGENUITY®; Alcon Inc. Technology, Fort Worth, TX, USA). The 3D-display unit consists of a camera, a processing unit, and a display, allowing the surgeon to be far from the ocular surface (see upper left inset). On the right, a surgical display reproduces the operating field in real time. This viewing system improves both the safety and efficiency of cataract surgery during the COVID-19 pandemic